Jim Krenn has extensive experience representing public and private companies and investors in significant business transactions from formation through liquidity. His practice focuses on mergers and acquisitions, venture capital financings, and emerging company counseling.
Mr. Krenn advises clients on private and public acquisitions on both the buy-side and sell-side across numerous transaction structures, including equity purchases, asset purchases, mergers, acquisitions, and divestitures of divisions and subsidiaries, cross-border transactions, and auctions. He has represented buyers and sellers in acquisitions and divestitures ranging from $1 million to over $1 billion.
Mr. Krenn counsels emerging and established life science and technology companies in equity financings and general corporate matters, and angel, corporate, and venture capital investors in investments in such companies. Mr. Krenn has represented clients in over $2 billion in equity and debt financings ranging from seed rounds to $100 million plus later stage rounds.
In addition, Mr. Krenn represents public companies in public offerings, other capital markets transactions, and SEC reporting and compliance matters, and advises boards of directors on corporate governance issues.
Mr. Krenn has represented clients in a broad range of industries, including biopharmaceutical, artificial intelligence, medical device, e-commerce, cybersecurity, software, Internet, social media, semiconductor, unmanned aerial vehicles, agtech, consumer products, finance, cleantech, action sports, and energy.
Mr. Krenn was recognized as “Best of the Bar” by the San Diego Business Journal in 2015. Mr. Krenn received his J.D., cum laude, from Harvard Law School. Mr. Krenn received his B.B.A., summa cum laude, in finance from the University of Notre Dame, where he was a recipient of the Hamilton Finance Award and the Eugene D. Fanning Award for exceptional achievement in business communication.
Representative M&A and Venture Financing Matters:
MERGERS AND ACQUISITIONS
©1996-2019 Morrison & Foerster LLP. All rights reserved.